By Matthäus Piatti, Vivian Eberle Initially posted on the BSPEC blog Cannabis, pot, marijuana, weed… This recently legalized industry expands far beyond dried cannabis (known as the “flower”) rolled up in a joint. Products such as oils, edibles, pills, beverages, creams for medical and recreational purposes; technology ranging from POS data analytics
Healthcare
Canadian Cannabis Industry Overview
Should I Buy Weed Stocks?
Global M&A Roundup Nov 24, 2017 – Cavium, Huaxia Life Insurance, DaVita Medical Group, Sun Art Retail
Our previous Canadian Mergers & Acquisitions roundups can be found here. Our previous global M&A roundups can be found here. Target: Cavium Inc Industry: Technology Acquirer: Cavium Inc Target: Marvell Technology Group Size: $6 Billion Consideration: Cash & Stock Sell Side Advisors: JP Morgan, Qatalyst Group Buy Side Advisors: Goldman Sachs Legal Advisors: Skadden Arps On November 20th 2017, Marvell technology group entered into
Canadian M&A Roundup Nov 17, 2017 – Weyburn/Cenovus, CanniMed Therapeutics, Care Investment Trust, General Growth Properties
Our previous Canadian Mergers & Acquisitions roundups can be found here. Our previous global M&A roundups can be found here. Target: Weyburn Unit and Minor Assets, Cenovus Energy Inc. Industry: Energy Acquirer: Whitecap Resources Inc. Target: Weyburn Unit and Minor Assets in southeast Saskatchewan, Cenovus Energy Inc. Size: CAD 940 million Consideration: 100% Cash Source of Funds: Debt, Equity
Global ECM Weekly Monitor Nov 17, 2017 – Alnylam Pharmaceuticals, Norwegian Cruise Line Holdings, Gardner Denver Holdings
Our previous Global ECM Weekly Monitors can be found here. Alnylam Pharmaceuticals, Inc. (NasdaqGS:ALNY) Announcement Date: November 13, 2017 Gross Offering Amount: USD $700 million Price per share: $125 Lead Banks: Goldman Sachs, JP Morgan, Barclays, Barclays Nature of the issue: Follow-on Equity Offering; General Corporate Purposes Security Issued: Common Stock Overallotment: $105
Global M&A Roundup Nov 10, 2017 – Hengda Real Estate, Mattel, Ortho-Clinical Diagnostics
Our previous Canadian Mergers & Acquisitions roundups can be found here. Our previous global M&A roundups can be found here. Target: Hengda Real Estate Group Industry: Real Estate Acquirer: Multiple buyers Target: Hengda Real Estate Group Size: 9.1 billion Consideration: Cash Sell Side Advisors: Undisclosed Buy Side Advisors: Gram Capital Legal Advisors: Undisclosed On November 6th,
Global M&A Roundup Oct 13, 2017 – eviCore healthcare, Bayer
Our previous Canadian Mergers & Acquisitions roundups can be found here. Our previous global M&A roundups can be found here. Target: eviCore healthcare, LLC Industry: Healthcare, Technology Acquirer: Oz Parent, Inc. Target: eviCore healthcare, LLC Size: $3.6 billion Consideration: 100% Cash Source of Funds: Cash, Debt Sell Side Advisors: JP Morgan, Morgan Stanley Buy Side
Global M&A Roundup Sep 15, 2017 – The New York State Catholic Health Plan, Inc.
Our previous Canadian Mergers & Acquisitions roundups can be found here. Our previous global M&A roundups can be found here. Target: The New York State Catholic Health Plan, Inc. Industry: Healthcare / Financial Institutions - Insurance Acquirer: Centene Corporation (NYSE:CNC) Target: The New York State Catholic Health Plan, Inc. Size: $3.75 billion Consideration: 100% Cash
Global M&A Roundup Sep 1, 2017 – Advisory Board Company, Kite Pharma
Our previous Canadian Mergers & Acquisitions roundups can be found here. Our previous global M&A roundups can be found here. Target: The Advisory Board Company (NasdaqGS:ABCO) Industry: Healthcare - Research and Consulting Services Acquirer: OptumInsight, Inc. Target: The Advisory Board Company Size: $2.9 billion Consideration: 92% Cash, 8% Equity Source of Funds: Cash, Common Stock